Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1726389

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1726389

U.S. Continuous Positive Airway Pressure Devices Market Size, Share & Trends Analysis Report By Connectivity (Connected, Non-connected), By End-use (Home Care Settings, Hospitals & Clinics), And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 3950
Printable PDF & Excel (5-User License)
USD 4950
Printable PDF & Excel (Enterprise License)
USD 6950

Add to Cart

Description

Table of Contents

List of Tables

U.S. Continuous Positive Airway Pressure Devices Market Growth & Trends:

The U.S. continuous positive airway pressure devices market is anticipated to reach USD 820.85 million by 2030, registering a CAGR of 4.44% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the increasing prevalence of sleep apnea and respiratory conditions, advancements in CPAP device technology, increased awareness and diagnosis of sleep apnea, and supportive reimbursement policies.

Technological advancements represent another crucial driver in the U.S. CPAP market. Continuous innovation has led to the development of more user-friendly, quieter, and compact devices, enhancing patient comfort and compliance. Introducing innovative technologies, such as remote monitoring and connectivity features, allows patients to track their sleep patterns and treatment progress, driving an active role in their healthcare.

Increased awareness campaigns by healthcare organizations and government bodies lead to more individuals seeking diagnosis and treatment for sleep apnea. In addition, favorable reimbursement policies by insurance providers make CPAP therapy more accessible to a broader population segment. Recognizing the long-term benefits of CPAP therapy in preventing complications associated with untreated sleep apnea also encourages healthcare providers to recommend and prescribe these devices frequently.

U.S. Continuous Positive Airway Pressure Devices Market Report Highlights:

  • On the basis of connectivity, the connected segment held the largest market share of 68.83% in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The growth of this segment is driven by advancements in sleep apnea management, including improved technology integration for real-time monitoring and tailored care, which enhances user adherence and treatment effectiveness.
  • On the basis of end use, the home care settings segment held the largest market share in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The expansion of this segment is driven by the increasing prevalence of obstructive sleep apnea (OSA) and advancements in CPAP technology, which are increasing the adoption of homecare CPAP therapy as an affordable, comfortable, and convenient solution for patients.
  • Some prominent players in the U.S. CPAP devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, and Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
  • In November 2024, Fisher & Paykel Healthcare introduced the F&P Nova Micro nasal pillow mask in the U.S., marking the company's smallest and lightest CPAP therapy mask so far.
Show more
Product Code: GVR-4-68040-556-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
    • 1.4.6. Research Assumption
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3
  • 1.9. List of Secondary Sources
  • 1.10. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. U.S. CPAP Devices Market
    • 2.1.1. Market Snapshot
    • 2.1.2. Segment Snapshot
      • 2.1.2.1. Connectivity segment outlook
      • 2.1.2.2. End Use segment outlook
    • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Rising incidence of obstructive sleep apnea (OSA)
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Supportive initiatives by government and private organizations for CPAP devices
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product recalls & failure
      • 3.3.2.2. Complex regulatory framework pertaining to CPAP devices
    • 3.3.3. Market Opportunity Analysis
      • 3.3.3.1. Growing adoption of CPAP devices in home care settings
    • 3.3.4. Market Challenges Analysis
      • 3.3.4.1. Regulatory and reimbursement challenges
  • 3.4. U.S. CPAP Devices Market Analysis Tools: PESTEL
    • 3.4.1. Political & Legal
    • 3.4.2. Economic & Social
    • 3.4.3. Technology
    • 3.4.4. Environment
  • 3.5. U.S. CPAP Market Analysis Tools: Porter's
  • 3.6. COVID 19 Impact Analysis

Chapter 4. U.S. CPAP Devices Market: Connectivity Estimates & Trend Analysis

  • 4.1. U.S. CPAP Devices Market: Connectivity Movement Analysis
  • 4.2. U.S. CPAP Devices Market: Connectivity Segment Dashboard
  • 4.3. Connectivity Movement & Market Share Analysis, 2024 & 2030
  • 4.4. U.S. Connectivity Market Estimates & Forecast, by Connectivity
  • 4.5. Connected
    • 4.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
    • 4.5.2. Bluetooth-Connected CPAP
      • 4.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
    • 4.5.3. Wi-Fi & Cellular Connected CPAP
      • 4.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
    • 4.5.4. Hybrid-Connected
      • 4.5.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 4.6. Non-Connected
    • 4.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)

Chapter 5. U.S. CPAP Devices Market: End Use Estimates & Trend Analysis

  • 5.1. U.S. CPAP Devices Market: End Use Movement Analysis
  • 5.2. U.S. CPAP Devices Market: End Use Segment Dashboard
  • 5.3. End Use Movement & Market Share Analysis, 2024 & 2030
  • 5.4. U.S. CPAP Devices Market Estimates & Forecast, by End Use
  • 5.5. Home Care Settings
    • 5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 5.6. Hospitals & Clinics
    • 5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 5.7. Others (Long-Term Care Facilities, etc.)
    • 5.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategies of Market Players for Entry and Exit and its Impact on Market Competitors
  • 6.3. Company Market Position Analysis
  • 6.4. Company Share Analysis, from 2012 to 2024 (%)
  • 6.5. Company Profiles/Listing
    • 6.5.1. ResMed
      • 6.5.1.1. Overview
      • 6.5.1.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Koninklijke Philips N.V.
      • 6.5.2.1. Overview
      • 6.5.2.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Fisher & Paykel Healthcare Limited
      • 6.5.3.1. Overview
      • 6.5.3.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. React Health (3B Medical)
      • 6.5.4.1. Overview
      • 6.5.4.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Lowenstein Medical
      • 6.5.5.1. Overview
      • 6.5.5.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. BMC Medical
      • 6.5.6.1. Overview
      • 6.5.6.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Wellell (Apex Medical)
      • 6.5.7.1. Overview
      • 6.5.7.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Armstrong Medical
      • 6.5.8.1. Overview
      • 6.5.8.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Breas Medical
      • 6.5.9.1. Overview
      • 6.5.9.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. SEFAM
      • 6.5.10.1. Overview
      • 6.5.10.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Smiths Group PLC
      • 6.5.11.1. Overview
      • 6.5.11.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Transcend Inc. (Somnetics International, Inc.)
      • 6.5.12.1. Overview
      • 6.5.12.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Trudell Medical (Vyaire)
      • 6.5.13.1. Overview
      • 6.5.13.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
      • 6.5.14.1. Overview
      • 6.5.14.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Invacare Corporation
      • 6.5.15.1. Overview
      • 6.5.15.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Others
      • 6.5.16.1. Overview
      • 6.5.16.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-556-8

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S continuous positive airway pressure devices market revenue estimates and forecast, by connectivity, 2018 - 2030 (USD Million) (000' Units)
  • Table 4 U.S continuous positive airway pressure devices market revenue estimates and forecast, by end use, 2018 - 2030 (USD Million) (000' Units)

List of Figures

  • Fig. 1 U.S CPAP Devices Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for Market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Technology segment outlook
  • Fig. 11 Application segment outlook
  • Fig. 12 End Use segment outlook
  • Fig. 13 Competitive landscape
  • Fig. 14 U.S CPAP Devices Market: Market dynamics
  • Fig. 15 U.S CPAP Devices Market: Porter's analysis
  • Fig. 16 U.S CPAP Devices Market: PESTLE analysis
  • Fig. 17 U.S CPAP Devices Market: Connectivity segment dashboard
  • Fig. 18 U.S CPAP Devices Market: Connectivity movement share analysis
  • Fig. 19 Connected Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 20 Bluetooth-Connected CPAP Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 21 Wi-Fi & Cellular Connected CPAP Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 22 Hybrid-Connected Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 23 Non-Connected Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 24 U.S CPAP Devices Market: End Use Segment Dashboard
  • Fig. 25 U.S CPAP Market: End Use Movement Share Analysis
  • Fig. 26 Home Care Settings Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 27 Hospitals & Clinics Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 28 Others (Long-Term Care Facilities, etc.) Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 29 Company categorization
  • Fig. 30 Company Market Share Analysis (2012 - 2024) Metrics Covered: Unit Volume, Average Selling Price (ASP), Market Value
  • Fig. 31 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!